JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=545785, encodeId=f5df545e8549, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：Journal of Microbiology and Biotechnology这个杂志大修后从7月10号under 2nd review 到 8月14号editor decision 之后， editor decision这个状态持续有一个星期多了，一直没有结果。折磨人啊，这整个八月份都很忐忑，不管是拒绝还是什么，希望能快点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/28/cc86b792f17ac9eb8b40d0625c7e84aa.jpg, createdBy=869b2042751, createdName=硕鼠阿宝, createdTime=Tue Aug 22 17:00:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218221, encodeId=f1841218221f5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：破骨细胞 经验分享：审稿审稿较快，1个多月左右，审完补了试验，逐条修改，返修后很快接受，投稿到接受差不多3个月。但是后面又投了2篇，秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f39a5245332, createdName=橘遥, createdTime=Mon May 09 16:48:45 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093659, encodeId=ba011093659b6, content=我的结果太多了，文章放不下，应该怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093660, encodeId=f9ac109366043, content=整理结果过程中，需要按照什么样的逻辑顺序整理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587964, encodeId=f55b58e96483, content=请问，现在知道这个杂种收费情况吗？谢谢★眼大无神★ 2018-10-28 00:00:00 发表: 请问收费么？, beContent=★眼大无神★ 2018-10-28 00:00:00 发表: 请问收费么？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffda5278727, createdName=1483ac32m95(暂无昵称), createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562454, encodeId=438156245455, content=请问收费么？Taoj1992 2018-03-16 发表:: 研究方向：生物催化;; 接收率：约50% 审稿时间：约2个月 SCI(2016)：1.75 SCI(2015)：1.685 SCI(2014)：1.525 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。Taoj1992 2018-03-16 14:17:00 发表: 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, beContent=Taoj1992 2018-03-16 发表:: 研究方向：生物催化;; 接收率：约50% 审稿时间：约2个月 SCI(2016)：1.75 SCI(2015)：1.685 SCI(2014)：1.525 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/14be5eb1ed131be901374da80ac2448a.jpg, createdBy=4ec92402937, createdName=★眼大无神★, createdTime=Sun Oct 28 00:00:00 CST 2018, time=2018-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553745, encodeId=4142553e4512, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4092004290, createdName=Taoj1992, createdTime=Fri Mar 16 14:17:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538337, encodeId=a52a53833e3f, content=请问这个杂志怎么投稿呢？没有在线投稿的地方，求助！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d742080242, createdName=891140246_89324301, createdTime=Thu Jun 22 11:21:00 CST 2017, time=2017-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537641, encodeId=e2f753e6413e, content=又涨了，1.75, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=420, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jun 13 00:00:00 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537640, encodeId=a1ae53e640c2, content=1.75, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jun 13 00:00:00 CST 2017, time=2017-06-13, status=1, ipAttribution=)]

2017-08-22 硕鼠阿宝

审稿速度:3.0 | 投稿命中率:25.0
经验分享：Journal of Microbiology and Biotechnology这个杂志大修后从7月10号under 2nd review 到 8月14号editor decision 之后， editor decision这个状态持续有一个星期多了，一直没有结果。折磨人啊，这整个八月份都很忐忑，不管是拒绝还是什么，希望能快点。

350 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=545785, encodeId=f5df545e8549, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：Journal of Microbiology and Biotechnology这个杂志大修后从7月10号under 2nd review 到 8月14号editor decision 之后， editor decision这个状态持续有一个星期多了，一直没有结果。折磨人啊，这整个八月份都很忐忑，不管是拒绝还是什么，希望能快点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/28/cc86b792f17ac9eb8b40d0625c7e84aa.jpg, createdBy=869b2042751, createdName=硕鼠阿宝, createdTime=Tue Aug 22 17:00:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218221, encodeId=f1841218221f5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：破骨细胞 经验分享：审稿审稿较快，1个多月左右，审完补了试验，逐条修改，返修后很快接受，投稿到接受差不多3个月。但是后面又投了2篇，秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f39a5245332, createdName=橘遥, createdTime=Mon May 09 16:48:45 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093659, encodeId=ba011093659b6, content=我的结果太多了，文章放不下，应该怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093660, encodeId=f9ac109366043, content=整理结果过程中，需要按照什么样的逻辑顺序整理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587964, encodeId=f55b58e96483, content=请问，现在知道这个杂种收费情况吗？谢谢★眼大无神★ 2018-10-28 00:00:00 发表: 请问收费么？, beContent=★眼大无神★ 2018-10-28 00:00:00 发表: 请问收费么？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffda5278727, createdName=1483ac32m95(暂无昵称), createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562454, encodeId=438156245455, content=请问收费么？Taoj1992 2018-03-16 发表:: 研究方向：生物催化;; 接收率：约50% 审稿时间：约2个月 SCI(2016)：1.75 SCI(2015)：1.685 SCI(2014)：1.525 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。Taoj1992 2018-03-16 14:17:00 发表: 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, beContent=Taoj1992 2018-03-16 发表:: 研究方向：生物催化;; 接收率：约50% 审稿时间：约2个月 SCI(2016)：1.75 SCI(2015)：1.685 SCI(2014)：1.525 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/14be5eb1ed131be901374da80ac2448a.jpg, createdBy=4ec92402937, createdName=★眼大无神★, createdTime=Sun Oct 28 00:00:00 CST 2018, time=2018-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553745, encodeId=4142553e4512, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4092004290, createdName=Taoj1992, createdTime=Fri Mar 16 14:17:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538337, encodeId=a52a53833e3f, content=请问这个杂志怎么投稿呢？没有在线投稿的地方，求助！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d742080242, createdName=891140246_89324301, createdTime=Thu Jun 22 11:21:00 CST 2017, time=2017-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537641, encodeId=e2f753e6413e, content=又涨了，1.75, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=420, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jun 13 00:00:00 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537640, encodeId=a1ae53e640c2, content=1.75, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jun 13 00:00:00 CST 2017, time=2017-06-13, status=1, ipAttribution=)]

2022-05-09 橘遥

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：破骨细胞
经验分享：审稿审稿较快，1个多月左右，审完补了试验，逐条修改，返修后很快接受，投稿到接受差不多3个月。但是后面又投了2篇，秒拒。

98 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=545785, encodeId=f5df545e8549, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：Journal of Microbiology and Biotechnology这个杂志大修后从7月10号under 2nd review 到 8月14号editor decision 之后， editor decision这个状态持续有一个星期多了，一直没有结果。折磨人啊，这整个八月份都很忐忑，不管是拒绝还是什么，希望能快点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/28/cc86b792f17ac9eb8b40d0625c7e84aa.jpg, createdBy=869b2042751, createdName=硕鼠阿宝, createdTime=Tue Aug 22 17:00:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218221, encodeId=f1841218221f5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：破骨细胞 经验分享：审稿审稿较快，1个多月左右，审完补了试验，逐条修改，返修后很快接受，投稿到接受差不多3个月。但是后面又投了2篇，秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f39a5245332, createdName=橘遥, createdTime=Mon May 09 16:48:45 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093659, encodeId=ba011093659b6, content=我的结果太多了，文章放不下，应该怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093660, encodeId=f9ac109366043, content=整理结果过程中，需要按照什么样的逻辑顺序整理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587964, encodeId=f55b58e96483, content=请问，现在知道这个杂种收费情况吗？谢谢★眼大无神★ 2018-10-28 00:00:00 发表: 请问收费么？, beContent=★眼大无神★ 2018-10-28 00:00:00 发表: 请问收费么？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffda5278727, createdName=1483ac32m95(暂无昵称), createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562454, encodeId=438156245455, content=请问收费么？Taoj1992 2018-03-16 发表:: 研究方向：生物催化;; 接收率：约50% 审稿时间：约2个月 SCI(2016)：1.75 SCI(2015)：1.685 SCI(2014)：1.525 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。Taoj1992 2018-03-16 14:17:00 发表: 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, beContent=Taoj1992 2018-03-16 发表:: 研究方向：生物催化;; 接收率：约50% 审稿时间：约2个月 SCI(2016)：1.75 SCI(2015)：1.685 SCI(2014)：1.525 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/14be5eb1ed131be901374da80ac2448a.jpg, createdBy=4ec92402937, createdName=★眼大无神★, createdTime=Sun Oct 28 00:00:00 CST 2018, time=2018-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553745, encodeId=4142553e4512, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4092004290, createdName=Taoj1992, createdTime=Fri Mar 16 14:17:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538337, encodeId=a52a53833e3f, content=请问这个杂志怎么投稿呢？没有在线投稿的地方，求助！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d742080242, createdName=891140246_89324301, createdTime=Thu Jun 22 11:21:00 CST 2017, time=2017-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537641, encodeId=e2f753e6413e, content=又涨了，1.75, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=420, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jun 13 00:00:00 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537640, encodeId=a1ae53e640c2, content=1.75, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jun 13 00:00:00 CST 2017, time=2017-06-13, status=1, ipAttribution=)]

2021-12-28 桑晒麦拉

我的结果太多了，文章放不下，应该怎么处理？

111 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=545785, encodeId=f5df545e8549, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：Journal of Microbiology and Biotechnology这个杂志大修后从7月10号under 2nd review 到 8月14号editor decision 之后， editor decision这个状态持续有一个星期多了，一直没有结果。折磨人啊，这整个八月份都很忐忑，不管是拒绝还是什么，希望能快点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/28/cc86b792f17ac9eb8b40d0625c7e84aa.jpg, createdBy=869b2042751, createdName=硕鼠阿宝, createdTime=Tue Aug 22 17:00:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218221, encodeId=f1841218221f5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：破骨细胞 经验分享：审稿审稿较快，1个多月左右，审完补了试验，逐条修改，返修后很快接受，投稿到接受差不多3个月。但是后面又投了2篇，秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f39a5245332, createdName=橘遥, createdTime=Mon May 09 16:48:45 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093659, encodeId=ba011093659b6, content=我的结果太多了，文章放不下，应该怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093660, encodeId=f9ac109366043, content=整理结果过程中，需要按照什么样的逻辑顺序整理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587964, encodeId=f55b58e96483, content=请问，现在知道这个杂种收费情况吗？谢谢★眼大无神★ 2018-10-28 00:00:00 发表: 请问收费么？, beContent=★眼大无神★ 2018-10-28 00:00:00 发表: 请问收费么？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffda5278727, createdName=1483ac32m95(暂无昵称), createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562454, encodeId=438156245455, content=请问收费么？Taoj1992 2018-03-16 发表:: 研究方向：生物催化;; 接收率：约50% 审稿时间：约2个月 SCI(2016)：1.75 SCI(2015)：1.685 SCI(2014)：1.525 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。Taoj1992 2018-03-16 14:17:00 发表: 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, beContent=Taoj1992 2018-03-16 发表:: 研究方向：生物催化;; 接收率：约50% 审稿时间：约2个月 SCI(2016)：1.75 SCI(2015)：1.685 SCI(2014)：1.525 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/14be5eb1ed131be901374da80ac2448a.jpg, createdBy=4ec92402937, createdName=★眼大无神★, createdTime=Sun Oct 28 00:00:00 CST 2018, time=2018-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553745, encodeId=4142553e4512, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4092004290, createdName=Taoj1992, createdTime=Fri Mar 16 14:17:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538337, encodeId=a52a53833e3f, content=请问这个杂志怎么投稿呢？没有在线投稿的地方，求助！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d742080242, createdName=891140246_89324301, createdTime=Thu Jun 22 11:21:00 CST 2017, time=2017-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537641, encodeId=e2f753e6413e, content=又涨了，1.75, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=420, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jun 13 00:00:00 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537640, encodeId=a1ae53e640c2, content=1.75, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jun 13 00:00:00 CST 2017, time=2017-06-13, status=1, ipAttribution=)]

2021-12-27 Mia

整理结果过程中，需要按照什么样的逻辑顺序整理？

119 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=545785, encodeId=f5df545e8549, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：Journal of Microbiology and Biotechnology这个杂志大修后从7月10号under 2nd review 到 8月14号editor decision 之后， editor decision这个状态持续有一个星期多了，一直没有结果。折磨人啊，这整个八月份都很忐忑，不管是拒绝还是什么，希望能快点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/28/cc86b792f17ac9eb8b40d0625c7e84aa.jpg, createdBy=869b2042751, createdName=硕鼠阿宝, createdTime=Tue Aug 22 17:00:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218221, encodeId=f1841218221f5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：破骨细胞 经验分享：审稿审稿较快，1个多月左右，审完补了试验，逐条修改，返修后很快接受，投稿到接受差不多3个月。但是后面又投了2篇，秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f39a5245332, createdName=橘遥, createdTime=Mon May 09 16:48:45 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093659, encodeId=ba011093659b6, content=我的结果太多了，文章放不下，应该怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093660, encodeId=f9ac109366043, content=整理结果过程中，需要按照什么样的逻辑顺序整理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587964, encodeId=f55b58e96483, content=请问，现在知道这个杂种收费情况吗？谢谢★眼大无神★ 2018-10-28 00:00:00 发表: 请问收费么？, beContent=★眼大无神★ 2018-10-28 00:00:00 发表: 请问收费么？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffda5278727, createdName=1483ac32m95(暂无昵称), createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562454, encodeId=438156245455, content=请问收费么？Taoj1992 2018-03-16 发表:: 研究方向：生物催化;; 接收率：约50% 审稿时间：约2个月 SCI(2016)：1.75 SCI(2015)：1.685 SCI(2014)：1.525 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。Taoj1992 2018-03-16 14:17:00 发表: 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, beContent=Taoj1992 2018-03-16 发表:: 研究方向：生物催化;; 接收率：约50% 审稿时间：约2个月 SCI(2016)：1.75 SCI(2015)：1.685 SCI(2014)：1.525 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/14be5eb1ed131be901374da80ac2448a.jpg, createdBy=4ec92402937, createdName=★眼大无神★, createdTime=Sun Oct 28 00:00:00 CST 2018, time=2018-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553745, encodeId=4142553e4512, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4092004290, createdName=Taoj1992, createdTime=Fri Mar 16 14:17:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538337, encodeId=a52a53833e3f, content=请问这个杂志怎么投稿呢？没有在线投稿的地方，求助！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d742080242, createdName=891140246_89324301, createdTime=Thu Jun 22 11:21:00 CST 2017, time=2017-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537641, encodeId=e2f753e6413e, content=又涨了，1.75, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=420, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jun 13 00:00:00 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537640, encodeId=a1ae53e640c2, content=1.75, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jun 13 00:00:00 CST 2017, time=2017-06-13, status=1, ipAttribution=)]

2020-04-02 1483ac32m95(暂无昵称)

请问，现在知道这个杂种收费情况吗？谢谢★眼大无神★ 2018-10-28 00:00:00 发表:
请问收费么？

★眼大无神★ 2018-10-28 00:00:00 发表: 请问收费么？

206 0

[GetPortalCommentsPageByObjectIdResponse(id=545785, encodeId=f5df545e8549, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：Journal of Microbiology and Biotechnology这个杂志大修后从7月10号under 2nd review 到 8月14号editor decision 之后， editor decision这个状态持续有一个星期多了，一直没有结果。折磨人啊，这整个八月份都很忐忑，不管是拒绝还是什么，希望能快点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/28/cc86b792f17ac9eb8b40d0625c7e84aa.jpg, createdBy=869b2042751, createdName=硕鼠阿宝, createdTime=Tue Aug 22 17:00:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218221, encodeId=f1841218221f5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：破骨细胞 经验分享：审稿审稿较快，1个多月左右，审完补了试验，逐条修改，返修后很快接受，投稿到接受差不多3个月。但是后面又投了2篇，秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f39a5245332, createdName=橘遥, createdTime=Mon May 09 16:48:45 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093659, encodeId=ba011093659b6, content=我的结果太多了，文章放不下，应该怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093660, encodeId=f9ac109366043, content=整理结果过程中，需要按照什么样的逻辑顺序整理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587964, encodeId=f55b58e96483, content=请问，现在知道这个杂种收费情况吗？谢谢★眼大无神★ 2018-10-28 00:00:00 发表: 请问收费么？, beContent=★眼大无神★ 2018-10-28 00:00:00 发表: 请问收费么？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffda5278727, createdName=1483ac32m95(暂无昵称), createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562454, encodeId=438156245455, content=请问收费么？Taoj1992 2018-03-16 发表:: 研究方向：生物催化;; 接收率：约50% 审稿时间：约2个月 SCI(2016)：1.75 SCI(2015)：1.685 SCI(2014)：1.525 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。Taoj1992 2018-03-16 14:17:00 发表: 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, beContent=Taoj1992 2018-03-16 发表:: 研究方向：生物催化;; 接收率：约50% 审稿时间：约2个月 SCI(2016)：1.75 SCI(2015)：1.685 SCI(2014)：1.525 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/14be5eb1ed131be901374da80ac2448a.jpg, createdBy=4ec92402937, createdName=★眼大无神★, createdTime=Sun Oct 28 00:00:00 CST 2018, time=2018-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553745, encodeId=4142553e4512, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4092004290, createdName=Taoj1992, createdTime=Fri Mar 16 14:17:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538337, encodeId=a52a53833e3f, content=请问这个杂志怎么投稿呢？没有在线投稿的地方，求助！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d742080242, createdName=891140246_89324301, createdTime=Thu Jun 22 11:21:00 CST 2017, time=2017-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537641, encodeId=e2f753e6413e, content=又涨了，1.75, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=420, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jun 13 00:00:00 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537640, encodeId=a1ae53e640c2, content=1.75, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jun 13 00:00:00 CST 2017, time=2017-06-13, status=1, ipAttribution=)]

2018-10-28 ★眼大无神★

请问收费么？Taoj1992 2018-03-16 发表::
研究方向：生物催化;; 接收率：约50% 审稿时间：约2个月 SCI(2016)：1.75 SCI(2015)：1.685 SCI(2014)：1.525 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。Taoj1992 2018-03-16 14:17:00 发表:
1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。

Taoj1992 2018-03-16 发表:: 研究方向：生物催化;; 接收率：约50% 审稿时间：约2个月 SCI(2016)：1.75 SCI(2015)：1.685 SCI(2014)：1.525 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。

145 0

[GetPortalCommentsPageByObjectIdResponse(id=545785, encodeId=f5df545e8549, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：Journal of Microbiology and Biotechnology这个杂志大修后从7月10号under 2nd review 到 8月14号editor decision 之后， editor decision这个状态持续有一个星期多了，一直没有结果。折磨人啊，这整个八月份都很忐忑，不管是拒绝还是什么，希望能快点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/28/cc86b792f17ac9eb8b40d0625c7e84aa.jpg, createdBy=869b2042751, createdName=硕鼠阿宝, createdTime=Tue Aug 22 17:00:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218221, encodeId=f1841218221f5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：破骨细胞 经验分享：审稿审稿较快，1个多月左右，审完补了试验，逐条修改，返修后很快接受，投稿到接受差不多3个月。但是后面又投了2篇，秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f39a5245332, createdName=橘遥, createdTime=Mon May 09 16:48:45 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093659, encodeId=ba011093659b6, content=我的结果太多了，文章放不下，应该怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093660, encodeId=f9ac109366043, content=整理结果过程中，需要按照什么样的逻辑顺序整理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587964, encodeId=f55b58e96483, content=请问，现在知道这个杂种收费情况吗？谢谢★眼大无神★ 2018-10-28 00:00:00 发表: 请问收费么？, beContent=★眼大无神★ 2018-10-28 00:00:00 发表: 请问收费么？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffda5278727, createdName=1483ac32m95(暂无昵称), createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562454, encodeId=438156245455, content=请问收费么？Taoj1992 2018-03-16 发表:: 研究方向：生物催化;; 接收率：约50% 审稿时间：约2个月 SCI(2016)：1.75 SCI(2015)：1.685 SCI(2014)：1.525 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。Taoj1992 2018-03-16 14:17:00 发表: 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, beContent=Taoj1992 2018-03-16 发表:: 研究方向：生物催化;; 接收率：约50% 审稿时间：约2个月 SCI(2016)：1.75 SCI(2015)：1.685 SCI(2014)：1.525 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/14be5eb1ed131be901374da80ac2448a.jpg, createdBy=4ec92402937, createdName=★眼大无神★, createdTime=Sun Oct 28 00:00:00 CST 2018, time=2018-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553745, encodeId=4142553e4512, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4092004290, createdName=Taoj1992, createdTime=Fri Mar 16 14:17:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538337, encodeId=a52a53833e3f, content=请问这个杂志怎么投稿呢？没有在线投稿的地方，求助！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d742080242, createdName=891140246_89324301, createdTime=Thu Jun 22 11:21:00 CST 2017, time=2017-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537641, encodeId=e2f753e6413e, content=又涨了，1.75, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=420, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jun 13 00:00:00 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537640, encodeId=a1ae53e640c2, content=1.75, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jun 13 00:00:00 CST 2017, time=2017-06-13, status=1, ipAttribution=)]

2018-03-16 Taoj1992

审稿速度:2.0 | 投稿命中率:50.0
经验分享：1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。

422 0

[GetPortalCommentsPageByObjectIdResponse(id=545785, encodeId=f5df545e8549, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：Journal of Microbiology and Biotechnology这个杂志大修后从7月10号under 2nd review 到 8月14号editor decision 之后， editor decision这个状态持续有一个星期多了，一直没有结果。折磨人啊，这整个八月份都很忐忑，不管是拒绝还是什么，希望能快点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/28/cc86b792f17ac9eb8b40d0625c7e84aa.jpg, createdBy=869b2042751, createdName=硕鼠阿宝, createdTime=Tue Aug 22 17:00:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218221, encodeId=f1841218221f5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：破骨细胞 经验分享：审稿审稿较快，1个多月左右，审完补了试验，逐条修改，返修后很快接受，投稿到接受差不多3个月。但是后面又投了2篇，秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f39a5245332, createdName=橘遥, createdTime=Mon May 09 16:48:45 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093659, encodeId=ba011093659b6, content=我的结果太多了，文章放不下，应该怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093660, encodeId=f9ac109366043, content=整理结果过程中，需要按照什么样的逻辑顺序整理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587964, encodeId=f55b58e96483, content=请问，现在知道这个杂种收费情况吗？谢谢★眼大无神★ 2018-10-28 00:00:00 发表: 请问收费么？, beContent=★眼大无神★ 2018-10-28 00:00:00 发表: 请问收费么？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffda5278727, createdName=1483ac32m95(暂无昵称), createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562454, encodeId=438156245455, content=请问收费么？Taoj1992 2018-03-16 发表:: 研究方向：生物催化;; 接收率：约50% 审稿时间：约2个月 SCI(2016)：1.75 SCI(2015)：1.685 SCI(2014)：1.525 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。Taoj1992 2018-03-16 14:17:00 发表: 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, beContent=Taoj1992 2018-03-16 发表:: 研究方向：生物催化;; 接收率：约50% 审稿时间：约2个月 SCI(2016)：1.75 SCI(2015)：1.685 SCI(2014)：1.525 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/14be5eb1ed131be901374da80ac2448a.jpg, createdBy=4ec92402937, createdName=★眼大无神★, createdTime=Sun Oct 28 00:00:00 CST 2018, time=2018-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553745, encodeId=4142553e4512, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4092004290, createdName=Taoj1992, createdTime=Fri Mar 16 14:17:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538337, encodeId=a52a53833e3f, content=请问这个杂志怎么投稿呢？没有在线投稿的地方，求助！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d742080242, createdName=891140246_89324301, createdTime=Thu Jun 22 11:21:00 CST 2017, time=2017-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537641, encodeId=e2f753e6413e, content=又涨了，1.75, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=420, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jun 13 00:00:00 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537640, encodeId=a1ae53e640c2, content=1.75, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jun 13 00:00:00 CST 2017, time=2017-06-13, status=1, ipAttribution=)]

2017-06-22 891140246_89324301

请问这个杂志怎么投稿呢？没有在线投稿的地方，求助！！！

536 0

[GetPortalCommentsPageByObjectIdResponse(id=545785, encodeId=f5df545e8549, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：Journal of Microbiology and Biotechnology这个杂志大修后从7月10号under 2nd review 到 8月14号editor decision 之后， editor decision这个状态持续有一个星期多了，一直没有结果。折磨人啊，这整个八月份都很忐忑，不管是拒绝还是什么，希望能快点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/28/cc86b792f17ac9eb8b40d0625c7e84aa.jpg, createdBy=869b2042751, createdName=硕鼠阿宝, createdTime=Tue Aug 22 17:00:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218221, encodeId=f1841218221f5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：破骨细胞 经验分享：审稿审稿较快，1个多月左右，审完补了试验，逐条修改，返修后很快接受，投稿到接受差不多3个月。但是后面又投了2篇，秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f39a5245332, createdName=橘遥, createdTime=Mon May 09 16:48:45 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093659, encodeId=ba011093659b6, content=我的结果太多了，文章放不下，应该怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093660, encodeId=f9ac109366043, content=整理结果过程中，需要按照什么样的逻辑顺序整理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587964, encodeId=f55b58e96483, content=请问，现在知道这个杂种收费情况吗？谢谢★眼大无神★ 2018-10-28 00:00:00 发表: 请问收费么？, beContent=★眼大无神★ 2018-10-28 00:00:00 发表: 请问收费么？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffda5278727, createdName=1483ac32m95(暂无昵称), createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562454, encodeId=438156245455, content=请问收费么？Taoj1992 2018-03-16 发表:: 研究方向：生物催化;; 接收率：约50% 审稿时间：约2个月 SCI(2016)：1.75 SCI(2015)：1.685 SCI(2014)：1.525 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。Taoj1992 2018-03-16 14:17:00 发表: 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, beContent=Taoj1992 2018-03-16 发表:: 研究方向：生物催化;; 接收率：约50% 审稿时间：约2个月 SCI(2016)：1.75 SCI(2015)：1.685 SCI(2014)：1.525 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/14be5eb1ed131be901374da80ac2448a.jpg, createdBy=4ec92402937, createdName=★眼大无神★, createdTime=Sun Oct 28 00:00:00 CST 2018, time=2018-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553745, encodeId=4142553e4512, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4092004290, createdName=Taoj1992, createdTime=Fri Mar 16 14:17:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538337, encodeId=a52a53833e3f, content=请问这个杂志怎么投稿呢？没有在线投稿的地方，求助！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d742080242, createdName=891140246_89324301, createdTime=Thu Jun 22 11:21:00 CST 2017, time=2017-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537641, encodeId=e2f753e6413e, content=又涨了，1.75, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=420, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jun 13 00:00:00 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537640, encodeId=a1ae53e640c2, content=1.75, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jun 13 00:00:00 CST 2017, time=2017-06-13, status=1, ipAttribution=)]

2017-06-13 Rtase

又涨了，1.75

420 0

[GetPortalCommentsPageByObjectIdResponse(id=545785, encodeId=f5df545e8549, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：Journal of Microbiology and Biotechnology这个杂志大修后从7月10号under 2nd review 到 8月14号editor decision 之后， editor decision这个状态持续有一个星期多了，一直没有结果。折磨人啊，这整个八月份都很忐忑，不管是拒绝还是什么，希望能快点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/28/cc86b792f17ac9eb8b40d0625c7e84aa.jpg, createdBy=869b2042751, createdName=硕鼠阿宝, createdTime=Tue Aug 22 17:00:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218221, encodeId=f1841218221f5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：破骨细胞 经验分享：审稿审稿较快，1个多月左右，审完补了试验，逐条修改，返修后很快接受，投稿到接受差不多3个月。但是后面又投了2篇，秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f39a5245332, createdName=橘遥, createdTime=Mon May 09 16:48:45 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093659, encodeId=ba011093659b6, content=我的结果太多了，文章放不下，应该怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093660, encodeId=f9ac109366043, content=整理结果过程中，需要按照什么样的逻辑顺序整理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587964, encodeId=f55b58e96483, content=请问，现在知道这个杂种收费情况吗？谢谢★眼大无神★ 2018-10-28 00:00:00 发表: 请问收费么？, beContent=★眼大无神★ 2018-10-28 00:00:00 发表: 请问收费么？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffda5278727, createdName=1483ac32m95(暂无昵称), createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562454, encodeId=438156245455, content=请问收费么？Taoj1992 2018-03-16 发表:: 研究方向：生物催化;; 接收率：约50% 审稿时间：约2个月 SCI(2016)：1.75 SCI(2015)：1.685 SCI(2014)：1.525 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。Taoj1992 2018-03-16 14:17:00 发表: 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, beContent=Taoj1992 2018-03-16 发表:: 研究方向：生物催化;; 接收率：约50% 审稿时间：约2个月 SCI(2016)：1.75 SCI(2015)：1.685 SCI(2014)：1.525 1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/14be5eb1ed131be901374da80ac2448a.jpg, createdBy=4ec92402937, createdName=★眼大无神★, createdTime=Sun Oct 28 00:00:00 CST 2018, time=2018-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553745, encodeId=4142553e4512, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：1月28日提交，2月26日小修，3月4日修回，3月12日接受，审稿时间大约2.5个礼拜，前后各有1个多礼拜稿子在编辑那边（可能是找审稿人和查重），总体效率很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4092004290, createdName=Taoj1992, createdTime=Fri Mar 16 14:17:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538337, encodeId=a52a53833e3f, content=请问这个杂志怎么投稿呢？没有在线投稿的地方，求助！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d742080242, createdName=891140246_89324301, createdTime=Thu Jun 22 11:21:00 CST 2017, time=2017-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537641, encodeId=e2f753e6413e, content=又涨了，1.75, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=420, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jun 13 00:00:00 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537640, encodeId=a1ae53e640c2, content=1.75, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jun 13 00:00:00 CST 2017, time=2017-06-13, status=1, ipAttribution=)]

2017-06-13 Rtase

1.75

489 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务